DENKA SEIKEN KABUSHIKI KAISHA – Trademark Portfolio

Entity Type: 03

DENKA SEIKEN KABUSHIKI KAISHA holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include QUICKNAVI and IMMUNO Q-SERA. The owner is based in Chuo-ku, Tokyo.

1-1 Nihonbashi-Muromachi 2-chome

Chuo-ku, Tokyo 103-8338 , JP

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DENKA SEIKEN KABUSHIKI KAISHA's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does DENKA SEIKEN KABUSHIKI KAISHA have?

DENKA SEIKEN KABUSHIKI KAISHA has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 2 cancelled.

What trademark classes does DENKA SEIKEN KABUSHIKI KAISHA file in?

DENKA SEIKEN KABUSHIKI KAISHA files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are DENKA SEIKEN KABUSHIKI KAISHA's most well-known trademarks?

DENKA SEIKEN KABUSHIKI KAISHA's registered trademark portfolio includes well-known marks such as QUICKNAVI and IMMUNO Q-SERA. These are among 2 currently registered trademarks in the portfolio.

What is DENKA SEIKEN KABUSHIKI KAISHA's trademark registration success rate?

DENKA SEIKEN KABUSHIKI KAISHA has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.